ALFERON N INJECTION
LOE Approachinginterferon alfa-n3
BLAVIAL
Approved
Oct 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ALFERON N INJECTION is a purified natural interferon alfa-N3 derived from human leukocytes, administered via intramuscular or intralesional injection. It is indicated for treatment of refractory or recurrent genital warts (condyloma acuminata) in patients who have failed or are unsuitable for other therapies. The drug works by activating natural killer cells and macrophages to enhance immune-mediated destruction of HPV-infected tissue.
LOE Approaching
With LOE approaching and moderate competitive pressure (30), this product faces significant revenue erosion; commercial teams should prepare for transition or consolidation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
HIV Infections
Career Relevance
Working on ALFERON N offers limited career growth, as the product is approaching loss of exclusivity with no clinical expansion pipeline and minimal linked job openings. This role is suitable for early-career professionals seeking experience in niche therapeutic areas or specialists managing declining brands through transition phases.
Medical Science Liaison
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.